Retinal Function in Parkinson's Disease
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Parkinson's disease (PD) is a neurodegenerative disorder characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and, in extreme cases, a loss of physical movement. The primary symptoms are the results of decreased stimulation of the motor cortex arising from the basal ganglia normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary symptoms may include high level cognitive dysfunction and subtle language problems. Included in the symptomatology experienced by patients with PD, visual abnormalities are not uncommon. Visual changes among patients with PD appear not only dynamic in nature, but differentially affected based on the course of the disease and, perhaps more importantly, its treatment. Parkinson's disease has significant ramifications not only in observation of irregularities in vision, but how vision interacts with entrainment of the circadian clock. The purpose of this study is to examine the relationship between PD and operation of a unique set of retinal cells known to regulate the circadian clock and sleep-wake cycles in human subjects.
| Condition |
|---|
|
Parkinson's Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Cross-Sectional |
| Official Title: | Intrinsically Photosensitive Retinal Ganglion Cells in Parkinson's Disease |
- pupillary threshold [ Time Frame: one ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 50 |
| Study Start Date: | October 2009 |
| Estimated Study Completion Date: | December 2010 |
| Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years to 64 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
movement disorders/neurology clinic
Inclusion Criteria: age 18-64 best corrected visual acuity of 20/25 or better in each eye -
Exclusion Criteria: evidence of any form of eye disease, inability to understand and sign informed consent.
-
Contacts and Locations| Contact: Bruce Ira Gaynes, OD, PharmD | 708-216-6262 | Bruce.Gaynes@va.gov |
| Contact: Jasvinder Chawla, MD | 708-202-3800 | Jasvinder.Chawla@va.gov |
| United States, Illinois | |
| Hines VA Medical Center | Recruiting |
| Hines, Illinois, United States, 60141 | |
| Contact: Bruce Ira Gaynes, OD, PharmD 708-216-6262 Bruce.Gaynes@va.gov | |
More Information
No publications provided
| Responsible Party: | Bruce I. Gaynes, OD, PharmD, Hines VA Medical Center |
| ClinicalTrials.gov Identifier: | NCT01010074 History of Changes |
| Other Study ID Numbers: | PD001 |
| Study First Received: | November 6, 2009 |
| Last Updated: | November 6, 2009 |
| Health Authority: | United States: Federal Government |
Keywords provided by Edward Hines Jr. VA Hospital:
|
retina, Parkinson's disease, ganglion cell, pupillary |
Additional relevant MeSH terms:
|
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases |
ClinicalTrials.gov processed this record on June 18, 2013